ONS Connections: Decreased sexual interest most common persistent and bothersome symptom in breast cancer survivors

Share this article:

PHOENIX—Breast cancer survivors reported that decreased sexual interest was the symptom causing the most significant bother. This research was presented at the Oncology Nursing Society (ONS) Connections: Advancing Care Through Science conference.

More symptoms are known to occur in breast cancer survivors compared with age-related peers. Among the 13.8 million cancer survivors in the United States, the majority are older than 65 years of age. Function is decreased by ongoing symptoms.

This research team conducted a secondary data analysis on a subset of 896 older breast cancer survivors from the American Cancer Society Study of Cancer Survivors II. Their symptoms were measured by a 30-item list, the Rotterdam Symptom Checklist, and a 4-point evaluation of the extent of bother. The research team calculated number of symptoms, symptom bother, and the prevalence of individual symptoms.

The symptoms that caused significant bother for more than 5% of the survivors studied included decreased sexual interest (21.1%), low back pain (8.6%), difficulty controlling urine (7.2%), pain (6.5%), tiredness (6.1%), and lack of energy (5.7%). More than 80% of these survivors reported no bother from symptoms that included vomiting (97.6%), sore mouth (92.3%), nausea (90.8%), shivering (86.3%), diarrhea (82.8%), and weight loss (81.4%).
The researchers noted that the Rotterdam Symptom Checklist, which they used for symptom reporting, includes many symptoms that were not prominent in post-treatment survivorship. Survivor-specific measures of symptoms are needed.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs